Related Experiment Videos

Neonatal hyperinsulinism

V M Schwitzgebel1, S E Gitelman

  • 1Department of Pediatrics, University of California at San Francisco, USA.

Clinics in Perinatology
|January 19, 1999
PubMed

Insights

Hyperinsulinism, a common cause of severe infant hypoglycemia, requires prompt diagnosis and treatment to prevent neurological damage. Recent research advances our understanding of its molecular causes and clinical management.

Area of Science:

  • Pediatric Endocrinology
  • Neonatal Medicine
  • Molecular Pathophysiology

Background:

  • Hyperinsulinism is the primary cause of persistent hypoglycemia in neonates and infants.
  • Neurologic sequelae can result from delayed diagnosis and inadequate treatment.
  • Understanding molecular and cellular mechanisms is crucial for effective management.

Purpose of the Study:

  • To review the latest advancements in hyperinsulinism pathophysiology.
  • To discuss clinical features and diagnostic hallmarks.
  • To outline current and emerging treatment strategies.

Main Methods:

  • Review of current literature on hyperinsulinism.
  • Analysis of molecular and cellular mechanisms.
  • Synthesis of clinical presentation and diagnostic criteria.
  • Evaluation of treatment options.

Main Results:

  • Hyperinsulinism presents diverse molecular and cellular derangements.
  • Key clinical features and diagnostic indicators are identified.
  • Various therapeutic approaches exist, from medical to surgical.

Conclusions:

  • Early diagnosis and aggressive treatment of hyperinsulinism are vital for preventing adverse neurologic outcomes.
  • Advances in understanding pathophysiology inform improved clinical management.
  • Multifaceted treatment strategies are essential for managing this complex condition.

Related Concept Videos